Successful Treatment of Hepatic Metastases of Hormone Refractory Prostate Cancer Using Radioligand Therapy With 177Lu-PSMA-617. [electronic resource]
- Clinical nuclear medicine Nov 2016
- 894-895 p. digital
Publication Type: Case Reports; Journal Article
1536-0229
10.1097/RLU.0000000000001358 doi
Aged, 80 and over Dipeptides--therapeutic use Heterocyclic Compounds, 1-Ring--therapeutic use Humans Liver Neoplasms--diagnostic imaging Lutetium Male Prostate-Specific Antigen Prostatic Neoplasms, Castration-Resistant--diagnostic imaging Radiopharmaceuticals--therapeutic use